| Literature DB >> 10549291 |
N Kubota1, Y Terauchi, H Miki, H Tamemoto, T Yamauchi, K Komeda, S Satoh, R Nakano, C Ishii, T Sugiyama, K Eto, Y Tsubamoto, A Okuno, K Murakami, H Sekihara, G Hasegawa, M Naito, Y Toyoshima, S Tanaka, K Shiota, T Kitamura, T Fujita, O Ezaki, S Aizawa, T Kadowaki.
Abstract
Agonist-induced activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) is known to cause adipocyte differentiation and insulin sensitivity. The biological role of PPAR gamma was investigated by gene targeting. Homozygous PPAR gamma-deficient embryos died at 10.5-11.5 dpc due to placental dysfunction. Quite unexpectedly, heterozygous PPAR gamma-deficient mice were protected from the development of insulin resistance due to adipocyte hypertrophy under a high-fat diet. These phenotypes were abrogated by PPAR gamma agonist treatment. Heterozygous PPAR gamma-deficient mice showed overexpression and hypersecretion of leptin despite the smaller size of adipocytes and decreased fat mass, which may explain these phenotypes at least in part. This study reveals a hitherto unpredicted role for PPAR gamma in high-fat diet-induced obesity due to adipocyte hypertrophy and insulin resistance, which requires both alleles of PPAR gamma.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10549291 DOI: 10.1016/s1097-2765(00)80210-5
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970